JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Differential polyamine metabolism in CHO cell lines: Insights into cell growth and antibody quality

  • 0Division of Biological Science and Technology, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon-do 26493, Republic of Korea.
New Biotechnology +

|

April 26, 2025

|

April 26, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Polyamines (PUT) impact Chinese hamster ovary (CHO) cell growth and antibody production differently across cell lines. Tailoring PUT levels in media can optimize bioprocess efficiency and therapeutic antibody quality.

Area Of Science

  • Biotechnology
  • Cell Biology
  • Biopharmaceutical Manufacturing

Background

  • Chinese hamster ovary (CHO) cell lines are crucial for biopharmaceutical production.
  • Genetic heterogeneity exists among CHO clones, affecting their behavior in cell culture.
  • Polyamines (PUT) are essential nutrients in cell culture media.

Purpose Of The Study

  • To investigate the cell line-specific effects of polyamine (PUT) withdrawal on CHO cell growth, metabolism, and antibody production.
  • To compare the responses of CHO-K1, CHO-S, and CHO-DG44 cell lines to PUT depletion.
  • To explore the potential of modulating PUT levels for optimizing antibody quality.

Main Methods

  • Culturing three distinct CHO cell lines (CHO-K1, CHO-S, CHO-DG44) under polyamine (PUT) replete and depleted conditions.
  • Assessing cell growth, viable cell density, and culture longevity.
  • Analyzing antibody yield, purity, charge heterogeneity, and glycosylation patterns.

Main Results

  • CHO-K1 cells showed significant growth reduction (77%) and decreased antibody yield/purity under PUT depletion.
  • CHO-S and CHO-DG44 cells exhibited greater resilience to PUT withdrawal, with CHO-DG44 showing a 25% reduction in cell density.
  • PUT depletion altered antibody charge heterogeneity and increased galactosylation across cell lines.

Conclusions

  • Cell line-specific responses to polyamine (PUT) availability necessitate tailored media formulations for CHO bioprocessing.
  • Modulating PUT levels presents a viable strategy for enhancing antibody production efficiency and quality.
  • Understanding PUT dependency is key to optimizing biopharmaceutical manufacturing processes and product characteristics.

Keywords: